Literature DB >> 1991638

Impaired sulphation of phenol by the colonic mucosa in quiescent and active ulcerative colitis.

B S Ramakrishna1, I C Roberts-Thomson, P R Pannall, W E Roediger.   

Abstract

Substantial amounts of phenols are produced in the human colon by bacterial fermentation of protein. In the colonic mucosa of animals, phenols are inactivated predominantly by conjugation with sulphate. The purpose of this study was to confirm sulphation of phenols by isolated colonocytes from man and to evaluate mucosal sulphation in inflammatory bowel disease using the phenol, paracetamol, in rectal dialysis bags. The incubation of paracetamol with colonocytes isolated from resected colon specimens (n = 7) yielded a mean (SE) value of 7.0 (0.9) mumols/g dry weight of paracetamol sulphate after 60 minutes but virtually undetectable values of paracetamol glucuronide. Paracetamol sulphate was detected in rectal dialysates from all control subjects, with a mean (SE) value of 4.2 (0.8) nmol/hour. Sulphation was significantly impaired (p less than 0.01) in 19 patients with active ulcerative colitis (0.6 (0.2) nmol/hour) and in 17 patients with ulcerative colitis in remission (1.1 (0.4) nmol/hour). Sulphation in eight patients with Crohn's colitis (4.3 (2.1) nmol/hour) was similar to that in control subjects. Impairment of the capacity of the mucosa to sulphate phenols in quiescent and active ulcerative colitis may pose a metabolic burden on colonic epithelial cells, which are continuously exposed to endogenous phenols from the colonic lumen.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1991638      PMCID: PMC1379212          DOI: 10.1136/gut.32.1.46

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  27 in total

1.  Biosynthesis of intestinal mucins. 3. Formation of active sulphate by cell-free extracts of sheep colonic mucosa.

Authors:  P W KENT; C A PASTERNAK
Journal:  Biochem J       Date:  1958-07       Impact factor: 3.857

2.  Cortisone in ulcerative colitis; final report on a therapeutic trial.

Authors:  S C TRUELOVE; L J WITTS
Journal:  Br Med J       Date:  1955-10-29

3.  Determination of simple phenols in faeces and urine by high-performance liquid chromatography.

Authors:  K E Murray; R F Adams
Journal:  J Chromatogr       Date:  1988-09-23

4.  High levels of faecal p-cresol in a group of hyperactive children.

Authors:  R F Adams; K E Murray; J W Earl
Journal:  Lancet       Date:  1985-12-07       Impact factor: 79.321

5.  Thiol S-methyltransferase: suggested role in detoxication of intestinal hydrogen sulfide.

Authors:  R A Weisiger; L M Pinkus; W B Jakoby
Journal:  Biochem Pharmacol       Date:  1980-10-15       Impact factor: 5.858

6.  Drug metabolism in rat colon: resolution of enzymatic constituents and characterization of activity.

Authors:  R J Oshinsky; H W Strobel
Journal:  Mol Cell Biochem       Date:  1987-05       Impact factor: 3.396

7.  Estimation of phenolic conjugation by colonic mucosa.

Authors:  B S Ramakrishna; D Gee; A Weiss; P Pannall; I C Roberts-Thomson; W E Roediger
Journal:  J Clin Pathol       Date:  1989-06       Impact factor: 3.411

8.  Histochemical demonstration of desialation and desulphation of normal and inflammatory bowel disease rectal mucus by faecal extracts.

Authors:  J M Rhodes; R R Black; R Gallimore; A Savage
Journal:  Gut       Date:  1985-12       Impact factor: 23.059

9.  1-Naphthol conjugation in isolated cells from liver, jejunum, ileum, colon and kidney of the guinea pig.

Authors:  M Schwenk; M Locher
Journal:  Biochem Pharmacol       Date:  1985-03-01       Impact factor: 5.858

10.  Colonic bicarbonate output as a test of disease activity in ulcerative colitis.

Authors:  W E Roediger; M J Lawson; V Kwok; A K Grant; P R Pannall
Journal:  J Clin Pathol       Date:  1984-06       Impact factor: 3.411

View more
  21 in total

Review 1.  Reinforcing the mucus: a new therapeutic approach for ulcerative colitis?

Authors:  P R Gibson; J G Muir
Journal:  Gut       Date:  2005-07       Impact factor: 23.059

Review 2.  Human colonocyte detoxification.

Authors:  W E Roediger; W Babidge
Journal:  Gut       Date:  1997-12       Impact factor: 23.059

3.  Sulfides impair short chain fatty acid beta-oxidation at acyl-CoA dehydrogenase level in colonocytes: implications for ulcerative colitis.

Authors:  W Babidge; S Millard; W Roediger
Journal:  Mol Cell Biochem       Date:  1998-04       Impact factor: 3.396

Review 4.  Stat3: friend or foe in colitis and colitis-associated cancer?

Authors:  Jie Han; Arianne L Theiss
Journal:  Inflamm Bowel Dis       Date:  2014-12       Impact factor: 5.325

Review 5.  The clinical experience with antiangiogenic agents.

Authors:  J L Marshall; M J Hawkins
Journal:  Breast Cancer Res Treat       Date:  1995       Impact factor: 4.872

6.  Impairment of mitochondrial acetoacetyl CoA thiolase activity in the colonic mucosa of patients with ulcerative colitis.

Authors:  Srikanth Santhanam; Aparna Venkatraman; Balakrishnan S Ramakrishna
Journal:  Gut       Date:  2007-05-04       Impact factor: 23.059

7.  Microbial-mammalian cometabolites dominate the age-associated urinary metabolic phenotype in Taiwanese and American populations.

Authors:  Jonathan R Swann; Konstantina Spagou; Matthew Lewis; Jeremy K Nicholson; Dana A Glei; Teresa E Seeman; Christopher L Coe; Noreen Goldman; Carol D Ryff; Maxine Weinstein; Elaine Holmes
Journal:  J Proteome Res       Date:  2013-06-24       Impact factor: 4.466

8.  Paracetamol metabolism in patients with ulcerative colitis.

Authors:  K V Haderslev; J Sonne; H E Poulsen; S Loft
Journal:  Br J Clin Pharmacol       Date:  1998-11       Impact factor: 4.335

9.  Selective inhibition of fatty acid oxidation in colonocytes by ibuprofen: a cause of colitis?

Authors:  W E Roediger; S Millard
Journal:  Gut       Date:  1995-01       Impact factor: 23.059

10.  Conjugation of 1-naphthol in human gastric epithelial cells.

Authors:  P Déchelotte; M Varrentrapp; H J Meyer; M Schwenk
Journal:  Gut       Date:  1993-02       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.